Fudging Clinical Trial Data Made Impossible by Blockchain Technology

Fudging Clinical Trial Data Made Impossible by Blockchain Technology

Blockchain technology can ensure the integrity of clinical trial data by making immutable records of trial protocols. Bitcoin was created with an intention of saving people’s lives from being ruined by the centralized monetary system and flawed policies framed by governments and central banks. When Satoshi Nakamoto published the white paper on Bitcoin, no one imagined that it may literally save lives in the long run. As developers continue to unearth new applications of Bitcoin’s underlying blockchain technology, one of the major breakthroughs of its application is in the field of drug....


Related News

Clinical Trials Show the Blockchain Can Stop ‘Fraudulent’ Science

Two doctors have recently devised a concept that makes clinical trial documents immutable using blockchain technology. A universal method of keeping clinical research untampered is an issue within the medical field. Often these trials can be manipulated, and the resulting treatment and medication can be over-exaggerated. A Peer-Reviewed Clinical Trial....

Mayo Clinic taps into blockchain technology for clinical trial design

The firm seeks to use Triall's medical software to create immutable clinical trial records. On Thursday, Dutch blockchain startup Triall announced that it has partnered with American nonprofit medical center Mayo Clinic to optimize clinical trial design and the management of study data. Starting this September, Triall's eClinical platform will support a two-year multi-center pulmonary arterial hypertension clinical trial that includes 10 research sites and more than 500 patients across the United States. The software will support activities such as data capture, document management, study....

US Food and Drug Administration to Study Blockchain Healthcare Applications

The US Food and Drug Administration (FDA), the government agency responsible for approving and regulating medical products, announced today its intent to study blockchain tech. Revealed in press materials published by IBM Watson Health, the research initiative will find the FDA teaming with IBM to explore how data from electronic medical records, clinical trials and health data from wearable devices could be better shared and audited using a blockchain. Initial tests will focus on clinical trials and real-world evidence data related to oncological data, according to the statements.....

BNP Paribas and Bank of Ireland Conducting Blockchain Trials

BNP Paribas and the Bank of Ireland have started trial runs for their respective blockchain applications. BNP Paribas has partnered with a crowdfunding platform, Smart Angels for the same. The banking sector is finally making some headway with their exploration of blockchain technology. Soon after UBS and Deutsche Bank made an announcement about the success of their blockchain technology experiment, two more international banks have now come up with their own solutions and testing them out. The French banking firm, BNP Paribas and the Bank of Ireland are the duo who have brought their....

ANZ Banking Group Trials Shared Ledger Technology

The shared ledger trial will continue for the foreseeable future, and ANZ hopes to see it reach its potential by the end of 2016. Ledger technology is of significant value to the financial sector, although it is unclear as to what role these different types of blockchains will play in the end. The Hyperledger Project helped “sponsor” a trial of shared ledger technology conducted by the ANZ banking group. Financial institutions are flocking towards blockchain technology and distributed ledgers these days, although it remains uncertain as to how this technology will be implemented in the....